These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36269944)

  • 1. Assessment of the COVID-19 vaccine market landscape in 2021 relative to challenges in low- and middle-income countries.
    Oddleifson DA; Kayani J; Shrivastava R; Tan J; Winters M; Forman H; Omer SB
    Hum Vaccin Immunother; 2022 Nov; 18(6):2124781. PubMed ID: 36269944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries.
    Peacocke EF; Heupink LF; Frønsdal K; Dahl EH; Chola L
    BMJ Open; 2021 Sep; 11(9):e049505. PubMed ID: 34593496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis.
    So AD; Woo J
    BMJ; 2020 Dec; 371():m4750. PubMed ID: 33323376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing research and development, launch, and scale up timelines of 18 vaccines: lessons learnt from COVID-19 and implications for other infectious diseases.
    Mao W; Zimmerman A; Urli Hodges E; Ortiz E; Dods G; Taylor A; Udayakumar K
    BMJ Glob Health; 2023 Sep; 8(9):. PubMed ID: 37696544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equal access of COVID-19 vaccine distribution in Africa: Challenges and way forward.
    Aborode AT; Olofinsao OA; Osmond E; Batubo AP; Fayemiro O; Sherifdeen O; Muraina L; Obadawo BS; Ahmad S; Fajemisin EA
    J Med Virol; 2021 Sep; 93(9):5212-5215. PubMed ID: 34009657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research priorities to reduce the impact of COVID-19 in low- and middle-income countries.
    Polašek O; Wazny K; Adeloye D; Song P; Chan KY; Bojude DA; Ali S; Bastien S; Becerra-Posada F; Borrescio-Higa F; Cheema S; Cipta DA; Cvjetković S; Castro LD; Ebenso B; Femi-Ajao O; Ganesan B; Glasnović A; He L; Heraud JM; Igwesi-Chidobe C; Iversen PO; Jadoon B; Karim AJ; Khan J; Biswas RK; Lanza G; Lee SW; Li Y; Liang LL; Lowe M; Islam MM; Marušić A; Mshelia S; Manyara AM; Htay MN; Parisi M; Peprah P; Sacks E; Akinyemi KO; Shahraki-Sanavi F; Sharov K; Rotarou ES; Stankov S; Supriyatiningsih W; Chan BT; Tremblay M; Tsimpida D; Vento S; Glasnović JV; Wang L; Wang X; Ng ZX; Zhang J; Zhang Y; Campbell H; Chopra M; Cousens S; Krstić G; Macdonald C; Mansoori P; Patel S; Sheikh A; Tomlinson M; Tsai AC; Yoshida S; Rudan I
    J Glob Health; 2022; 12():09003. PubMed ID: 35475006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility.
    Eccleston-Turner M; Upton H
    Milbank Q; 2021 Jun; 99(2):426-449. PubMed ID: 33650737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global inequity creates local insufficiency: A qualitative study of COVID-19 vaccine implementation challenges in low-and-middle-income countries.
    Haldane V; Ariyarajah A; Berry I; Loutet M; Salamanca-Buentello F; Upshur REG
    PLoS One; 2023; 18(2):e0281358. PubMed ID: 36780502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Global Survey of COVID-19 Vaccine Acceptance Among Healthcare Workers.
    Noushad M; Rastam S; Nassani MZ; Al-Saqqaf IS; Hussain M; Yaroko AA; Arshad M; Kirfi AM; Koppolu P; Niazi FH; Elkandow A; Darwish M; Abdalla Nassar AS; Abuzied Mohammed SO; Abdalrady Hassan NH; Abusalim GS; Samran A; Alsalhani AB; Demachkia AM; de Melo RM; Luddin N; Husein A; Habib A; Suleyman F; Osman HA; Al-Awar MS; Dimashkieh MR; Swapna LA; Barakat A; Alqerban A
    Front Public Health; 2021; 9():794673. PubMed ID: 35211453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International Efforts and Next Steps to Advance COVID-19 Vaccines Research and Production in Low- and Middle-Income Countries.
    Du L; Wang M; Raposo VL
    Vaccines (Basel); 2021 Dec; 10(1):. PubMed ID: 35062703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ensuring the global COVID-19 vaccine equity: Universal vaccine access strategy in the context of low and-middle-income countries.
    Parray AA; Yadav UN; Das A; Ali AM; Mollick S; Saha S; Mistry SK
    Glob Public Health; 2022 Apr; 17(4):614-621. PubMed ID: 35050840
    [No Abstract]   [Full Text] [Related]  

  • 12. The impact of delayed access to COVID-19 vaccines in low- and lower-middle-income countries.
    Duroseau B; Kipshidze N; Limaye RJ
    Front Public Health; 2022; 10():1087138. PubMed ID: 36711400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equitable access to COVID-19 vaccines makes a life-saving difference to all countries.
    Ye Y; Zhang Q; Wei X; Cao Z; Yuan HY; Zeng DD
    Nat Hum Behav; 2022 Feb; 6(2):207-216. PubMed ID: 35102361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 vaccine challenges: What have we learned so far and what remains to be done?
    Forman R; Shah S; Jeurissen P; Jit M; Mossialos E
    Health Policy; 2021 May; 125(5):553-567. PubMed ID: 33820678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccines: New challenges, new paradigms, new opportunities: Report of the 22nd DCVMN Annual General Meeting.
    Kumar Suri R; Hayman B; Prasad SD; Makhoana M; Tippoo P
    Vaccine; 2022 Jun; 40(26):3495-3505. PubMed ID: 35577632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Market Failure, State Failure: The Political Economy of Supply Chain Strengthening to Ensure Equitable Access to Vaccines and Medicines in Low- and Middle-Income Countries.
    Fox A
    J Health Polit Policy Law; 2024 Feb; 49(1):43-72. PubMed ID: 37522368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study.
    Clark RA; Mukandavire C; Portnoy A; Weerasuriya CK; Deol A; Scarponi D; Iskauskas A; Bakker R; Quaife M; Malhotra S; Gebreselassie N; Zignol M; Hutubessy RCW; Giersing B; Jit M; Harris RC; Menzies NA; White RG
    Lancet Glob Health; 2023 Apr; 11(4):e546-e555. PubMed ID: 36925175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunities.
    Dal-Ré R; Bekker LG; Gluud C; Holm S; Jha V; Poland GA; Rosendaal FR; Schwarzer-Daum B; Sevene E; Tinto H; Voo TC; Sreeharan N
    Lancet Infect Dis; 2021 Nov; 21(11):e342-e347. PubMed ID: 34019801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 vaccine equity: a health systems and policy perspective.
    Van De Pas R; Widdowson MA; Ravinetto R; N Srinivas P; Ochoa TJ; Fofana TO; Van Damme W
    Expert Rev Vaccines; 2022 Jan; 21(1):25-36. PubMed ID: 34758678
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.